If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAptitude Software Group Regulatory News (APTD)

Share Price Information for Aptitude Software Group (APTD)

Share Price is delayed by 15 minutes
Get Live Data
204.00    6.00 (3.03%)
Bid:
201.00
Ask:
204.00
Spread: 3.00 (1.493%)
Market Cap: £109.18m
APTD Live PriceLast checked at - London Stock Exchange

Intraday Aptitude Software Group Share Chart

Interim Management Statement and Special Dividend

1 Nov 2011 07:00

RNS Number : 2017R
Microgen PLC
01 November 2011
 



microgen

www.microgen.com

 

1 November 2011

 

INTERIM MANAGEMENT STATEMENT AND SPECIAL DIVIDEND

 

Microgen plc ('Microgen' or 'the Group') provides its Interim Management Statement covering the period from 1 July 2011 to the date of this announcement. Microgen released its interim results for the six months ending 30 June 2011 on 21 July 2011.

 

There have been no significant changes since 1 July 2011 in the trading or financial position of Microgen and its balance sheet remains strong. In September, Microgen repaid the £1.6 million loan associated with its Fleet freehold property, after which the Group had cash at 30 September 2011 of £26.0 million (Net Funds at 30 June 2011 : £25.2 million).

 

Since 1 July 2011 the Microgen Aptitude Solutions Division ("MASD") has further expanded its customer base and the Financial Systems Division ("FSD") continues to perform satisfactorily in a flat market environment. Due in part to the consultancy demand on a number of projects in 2011, the Group's performance is now anticipated to be moderately ahead of the Board's expectations for the year, although the Board remains cautious due to the current macro-economic environment.

 

As a result of the strong financial position of Microgen, the Board has decided to pay a special dividend of 5.0 pence per share. The special dividend will be paid on 9 December 2011 to shareholders on the register as at 11 November 2011.

 

Three years ago, in October 2008, the Board introduced the Value Enhancement and Realisation Bonus Scheme ("VERBS"), at which time the market capitalisation of Microgen was £37.0 million. Including the forthcoming special dividend the Board has, since the introduction of VERBS, returned £28.2 million to shareholders through a progressive dividend policy, special dividends and tender offers. This is equivalent to over 75% of the Group's market capitalisation at the time of the introduction of VERBS. Furthermore, Microgen's market capitalisation, at 31 October 2011, has increased to £122.9 million.

 

 

 

Contacts

Martyn Ratcliffe, Chairman 020-7496-8100

David Sherriff, Chief Executive Officer

Philip Wood, Group Finance Director

 

James Melville-Ross, FTI Consulting 020-7831-3113

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSUAABRAOAROAA
Date   Source Headline
17th Sep 20247:00 amRNSTransaction in Own Shares
16th Sep 20247:00 amRNSTransaction in Own Shares
13th Sep 20247:00 amRNSTransaction in Own Shares
12th Sep 20247:00 amRNSTransaction in Own Shares
11th Sep 20247:00 amRNSTransaction in Own Shares
10th Sep 20247:00 amRNSTransaction in Own Shares
9th Sep 20247:00 amRNSTransaction in Own Shares
6th Sep 20247:00 amRNSGrant of awards under 2016 Performance Share Plan
6th Sep 20247:00 amRNSTransaction in Own Shares
5th Sep 20247:00 amRNSTransaction in Own Shares
4th Sep 20247:00 amRNSTransaction in Own Shares
3rd Sep 202411:40 amRNSTotal Voting Rights
3rd Sep 20247:00 amRNSTransaction in Own Shares
2nd Sep 20247:00 amRNSTransaction in Own Shares
29th Aug 20247:00 amRNSTransaction in Own Shares
28th Aug 20247:00 amRNSTransaction in Own Shares
27th Aug 20247:00 amRNSTransaction in Own Shares
19th Aug 20247:00 amRNSTransaction in Own Shares
16th Aug 20247:00 amRNSTransaction in Own Shares
15th Aug 20247:00 amRNSTransaction in Own Shares
14th Aug 20247:00 amRNSTransaction in Own Shares
13th Aug 20247:00 amRNSTransaction in Own Shares
12th Aug 20247:00 amRNSTransaction in Own Shares
8th Aug 20247:00 amRNSTransaction in Own Shares
7th Aug 20247:00 amRNSTransaction in Own Shares
6th Aug 20247:00 amRNSTransaction in Own Shares
2nd Aug 20247:00 amRNSTransaction in Own Shares
1st Aug 202410:07 amRNSTotal Voting Rights
1st Aug 20247:00 amRNSTransaction in Own Shares
31st Jul 20247:00 amRNSTransaction in Own Shares
30th Jul 20247:00 amRNSTransaction in Own Shares
25th Jul 20247:00 amRNSInterim Results
25th Jul 20247:00 amRNSTransaction in Own Shares
24th Jul 20247:00 amRNSTransaction in Own Shares
23rd Jul 20247:00 amRNSTransaction in Own Shares
18th Jul 20247:00 amRNSTransaction in Own Shares
15th Jul 20247:00 amRNSTrading Update and Notice of Results
12th Jul 20247:00 amRNSTransaction in Own Shares
8th Jul 20247:00 amRNSTransaction in Own Shares
4th Jul 20247:00 amRNSTransaction in Own Shares
3rd Jul 20247:00 amRNSTransaction in Own Shares
2nd Jul 20247:00 amRNSTransaction in Own Shares
1st Jul 20247:00 amRNSTotal Voting Rights
1st Jul 20247:00 amRNSFynapse contract win with major existing client
1st Jul 20247:00 amRNSTransaction in Own Shares
28th Jun 20247:00 amRNSTransaction in Own Shares
27th Jun 20247:00 amRNSTransaction in Own Shares
26th Jun 20247:00 amRNSNotification of Major Holdings
18th Jun 20247:00 amRNSFynapse Investor Insights Session
17th Jun 20247:00 amRNSFynapse contract win in partnership with HSO

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.